[go: up one dir, main page]

NO981687L - Lubeluzole N-oxide - Google Patents

Lubeluzole N-oxide

Info

Publication number
NO981687L
NO981687L NO981687A NO981687A NO981687L NO 981687 L NO981687 L NO 981687L NO 981687 A NO981687 A NO 981687A NO 981687 A NO981687 A NO 981687A NO 981687 L NO981687 L NO 981687L
Authority
NO
Norway
Prior art keywords
oxide
lubeluzole
medicine
compositions
preparing
Prior art date
Application number
NO981687A
Other languages
Norwegian (no)
Other versions
NO981687D0 (en
Inventor
Raymond Antoine Stokbroekx
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of NO981687D0 publication Critical patent/NO981687D0/en
Publication of NO981687L publication Critical patent/NO981687L/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Den foreliggende oppfinnelsen vedrører lubeluzol N- oksid(er), sammensetninger som omfatter N- oksiden(e), fremgangsmåter ved fremstilling av dem og deres bruk som en medisin, spesielt i behand- lingen av tilstander som involverer cerebral hypoksi.The present invention relates to lubeluzole N-oxide (s), compositions comprising the N-oxide (s), methods of preparing them and their use as a medicine, particularly in the treatment of conditions involving cerebral hypoxia.

NO981687A 1995-10-25 1998-04-15 Lubeluzole N-oxide NO981687L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP95202887 1995-10-25
PCT/EP1996/004608 WO1997015572A1 (en) 1995-10-25 1996-10-21 Lubeluzole n-oxide

Publications (2)

Publication Number Publication Date
NO981687D0 NO981687D0 (en) 1998-04-15
NO981687L true NO981687L (en) 1998-04-15

Family

ID=8220766

Family Applications (1)

Application Number Title Priority Date Filing Date
NO981687A NO981687L (en) 1995-10-25 1998-04-15 Lubeluzole N-oxide

Country Status (9)

Country Link
EP (1) EP0843674A1 (en)
JP (1) JPH11513699A (en)
CN (1) CN1200122A (en)
AU (1) AU7298296A (en)
CA (1) CA2228054A1 (en)
IL (1) IL123083A0 (en)
NO (1) NO981687L (en)
WO (1) WO1997015572A1 (en)
ZA (2) ZA968952B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6355243B1 (en) 1999-11-13 2002-03-12 Bayer Corporation Method of thrombolysis by local delivery of active plasmin
US7544500B2 (en) 1999-11-13 2009-06-09 Talecris Biotherapeutics, Inc. Process for the production of a reversibly inactive acidified plasmin composition
PL2403865T3 (en) 2009-03-03 2016-01-29 Grifols Therapeutics Inc Methods for preparing plasminogen
EP2949721B1 (en) 2013-01-23 2018-07-18 Adeka Corporation Antistatic agent, antistatic agent composition, antistatic resin composition, and molded body

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4306069A (en) * 1980-06-19 1981-12-15 Mead Johnson & Company Encainide N-oxide
CA1260474A (en) * 1984-12-03 1989-09-26 Raymond A. Stokbroekx Benzoxazol- and benzothiazolamine derivatives
ZW1992A1 (en) * 1991-02-25 1993-09-22 Janssen Pharmaceutica Nv 4-/(2-benzotiazolyl)methylamino/-b-/(3,4-difluorephenoxy)methyl/-1-piperidine ethanol

Also Published As

Publication number Publication date
NO981687D0 (en) 1998-04-15
CA2228054A1 (en) 1997-05-01
IL123083A0 (en) 1998-09-24
ZA968952B (en) 1998-04-24
CN1200122A (en) 1998-11-25
AU7298296A (en) 1997-05-15
JPH11513699A (en) 1999-11-24
EP0843674A1 (en) 1998-05-27
WO1997015572A1 (en) 1997-05-01
MX9803272A (en) 1998-09-30
ZA968961B (en) 1998-04-24

Similar Documents

Publication Publication Date Title
NO991732L (en) New heterocyclylmethyl substituted pyrazole derivatives
NO992400L (en) New substituted pyrazole derivatives
TR199900083T2 (en) Crystal form of clarithromycin I.
MY133392A (en) Novel substituted pyrazole derivatives
NO20075065L (en) Use of isoflavone compounds to treat heart disease
WO1996013512A3 (en) L-ribofuranosyl nucleosides
ATE233738T1 (en) SMALL MOLECULES APPLICABLE IN THE TREATMENT OF INFLAMMATORY DISEASES
ATE213164T1 (en) USE OF NONA- AND DECAPEPTIDES FOR PRODUCING A MEDICINAL PRODUCT TO FIGHT AIDS
PL317705A1 (en) Pyrazole and pyrrole pyridines
NO20013003L (en) Quinoline derivatives
DK0973735T3 (en) Polyaromatic antiviral preparations
IL117091A (en) Methylphenyloxazolidinone derivatives pharmaceutical compositions containing the same and processes for the preparation threreof
NO963462L (en) Paramunity inducers based on combinations of poxvirus components, process for their preparation and use as a drug
HUP0401592A2 (en) Modafinil compound and cyclodextrin mixtures, process for their preparation and compositions containing them
NO20012428L (en) Substituted caprolactams, pharmaceutical compositions containing them and their use in the treatment of tumors
NO962006L (en) Substituted benzyloxycarbonylguanidines, process for their preparation, their use as drug or diagnostic as well as drug containing them
WO1996013498A3 (en) L-erythrosyl nucleosides
NO981687L (en) Lubeluzole N-oxide
DK0727416T3 (en) Substituted benzenesulfonylureas and thioureas, and process for their preparation, their use as
HU9201799D0 (en) New 2-amino-5-ciano-1,4-dihydropiridine-derivatives, process for their use and their use as medicaments
NO970178D0 (en) Terpenoid derivatives (sarcodictyins) useful as antitumor agents
SE9400524D0 (en) energy Preparations
ATE548048T1 (en) ONCOMODULIN FOR THE TREATMENT OF NEUROLOGICAL DISEASES
NO972111L (en) 6-Methoxy-1H-benzotriazole-5-carboxamide derivatives, process of their preparation and medical compositions containing them
EP1435901A4 (en) Hair treatment compositions and methods